|
Re: Dr. Ray versus Donald McCaffrey - A huge disconnect...
|
4
|
Resverlogix Corp.
|
Nov 20, 2019 07:15AM
|
|
Re: For Scientists - Nature article/study on epigenetic changes after kidney injury
|
4
|
Resverlogix Corp.
|
Jul 24, 2020 07:19AM
|
|
RVX 131003 AGM Meeting
|
4
|
Resverlogix Corp.
|
May 20, 2015 01:21PM
|
|
Re: Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial
|
4
|
Resverlogix Corp.
|
Sep 30, 2019 07:56AM
|
|
Re: This is what I think might be going on.....
|
4
|
Resverlogix Corp.
|
Sep 13, 2017 03:23AM
|
|
Chemical probes targeting epigenetic proteins: Applications beyond oncology
|
4
|
Resverlogix Corp.
|
Aug 04, 2017 10:29PM
|
|
Re: Apabetalone and FXR
|
4
|
Resverlogix Corp.
|
Jun 28, 2018 03:01PM
|
|
Re: Apabetalone and FXR
|
4
|
Resverlogix Corp.
|
Jun 28, 2018 03:10PM
|
|
Re: Credit Suisse was the big seller....
|
4
|
Resverlogix Corp.
|
Dec 11, 2018 12:03AM
|
|
COVID-19 and BRD4: a stormy and cardiotoxic bromo-romance
|
4
|
Resverlogix Corp.
|
Nov 10, 2021 10:44AM
|
|
New but not new Article
|
4
|
Resverlogix Corp.
|
Jun 23, 2021 11:32PM
|
|
Don Bio at Wallmine
|
4
|
Resverlogix Corp.
|
Oct 06, 2020 08:32PM
|
|
Re: Covid PIII Questions and Thoughts
|
4
|
Resverlogix Corp.
|
May 25, 2022 09:50PM
|
|
Re: Apropos AGM
|
4
|
Resverlogix Corp.
|
Jun 08, 2022 02:31AM
|
|
Couple of marginally relevant articles
|
4
|
Resverlogix Corp.
|
May 26, 2022 01:52AM
|
|
Re: Ethics Approval?
|
4
|
Resverlogix Corp.
|
Oct 19, 2021 05:04PM
|
|
Re: In Brief Published: 14 May 2021 CARDIOVASCULAR RISK Apabetalone in chronic kidney disease
|
4
|
Resverlogix Corp.
|
May 21, 2021 02:01AM
|
|
Re: Finance
|
4
|
Resverlogix Corp.
|
Apr 13, 2021 11:44PM
|
|
Re: In Brief Published: 14 May 2021 CARDIOVASCULAR RISK Apabetalone in chronic kidney disease
|
4
|
Resverlogix Corp.
|
May 21, 2021 02:08AM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
4
|
Resverlogix Corp.
|
Apr 12, 2021 12:37PM
|
